Moneyview IPO: GMP, allotment status, Oct 1 listing

Moneyview IPO is one of the most discussed mainboard listings across Reddit and social feeds this week, largely because of its heavy subscription and a moving grey-market premium (GMP). The issue was open from September 24, 2026 to September 28, 2026, and is scheduled to list on both NSE and BSE on October 1, 2026. Social posts have focused on three things - the 98.46 times subscription, the allotment timeline, and whether GMP-based estimates translate into actual listing-day prices. The IPO price band was set at Rs 32-34 per share, with a face value of Rs 1. The issue size has been widely cited at around Rs 1,091.68 crore (also referenced as Rs 1,091.61 crore in some trackers). With allotment finalisation due September 29 and shares expected to credit on September 30, attention has shifted to status checks and listing-day expectations. GMP remains an unofficial indicator, and posters repeatedly flag that it does not guarantee either listing price or post-listing performance.

Subscription ends at 98.46x, per NSE data

Moneyview IPO closed with an overall subscription of 98.46 times by the end of bidding on September 28, according to widely shared NSE data. Social posts highlighted that the demand was not marginal but broad-based, with strong participation from larger pools of capital. One data point that kept circulating was the scale of bids versus shares offered. The issue reportedly received bids for about 2,290 crore shares against about 23.25 crore shares on offer. Another social update from early in the book-build noted bids of 33,48,61,002 shares against 23,25,24,175 shares available, reflecting how interest built up early. This level of oversubscription has been a key reason the IPO stayed on trend lists for multiple days. The discussion also picked up because the subscription strength coincided with positive GMP quotes. As a result, most retail conversations moved quickly from “should you subscribe” to “did you get allotment”.

QIB and NII demand stayed in focus

A repeated theme across posts was that subscription was led by strong demand from QIBs and NIIs. This is notable because social sentiment often differentiates between headline oversubscription and the quality of demand driving it. On Day 1, several trackers highlighted that Non-Institutional Investors led the demand at that stage, subscribing 2.43 times the available shares. As the issue progressed, the narrative shifted to stronger institutional participation, with final-day commentary emphasising QIB and NII strength. Retail chatter frequently treats QIB interest as a confidence marker, even though it does not predict listing performance. Another point trending in forums was the sheer volume of applications, with one widely shared note citing over 48.55 lakh applications. Some posts also mentioned bids aggregating to nearly Rs 77,850 crore, reflecting how large the order book looked in value terms. At the same time, multiple threads reminded readers that subscription alone does not lock in listing gains. The most practical takeaway for applicants has been to track allotment updates and demat credit timelines.

Issue size and structure: fresh issue plus OFS

Moneyview IPO is being discussed as a Rs 1,091.68-crore mainboard offering. The structure shared across posts includes a fresh issue and an offer for sale (OFS). The fresh issue was cited as 22.06 crore shares aggregating to Rs 750 crore. The OFS component was cited as 10.05 crore shares worth Rs 341.68 crore. Combined, several trackers also referenced a total issue size of 32,10,82,435 shares. These details mattered in social conversations because they shape how people interpret the fund-raise and seller participation. Many retail posts did not go beyond the split, but the fresh issue versus OFS breakdown was still widely quoted. The same threads also repeated the IPO price band and the expected listing date. Overall, the structure discussion stayed factual and secondary to GMP and allotment. Still, it provided context for why the deal size and interest levels were drawing attention.

Price band and lot size: what applicants actually bought

The IPO price band was Rs 32 to Rs 34 per share. Most retail conversations treated the upper end of Rs 34 as the reference for GMP-based listing estimates. Moneyview’s face value was shared as Rs 1 per share, a standard detail that came up in allotment explainers. The market lot size was 441 shares, and applications were in multiples of this lot size. This lot size became central in posts calculating potential listing-day value based on assumed listing prices. It also influenced allotment probability discussions because retail allotments are typically in one-lot units when the issue is heavily oversubscribed. Several posts noted that listing is expected on both NSE and BSE, which matters for applicants tracking where their broker will show the security first. For many users, the key was not theoretical pricing but whether they received 441 shares at all. With strong subscription, the conversation moved toward realistic chances of allotment rather than only headline gains.

GMP moved in a Rs 3 to Rs 15 band, with mild correction

Grey-market premium was one of the most shared metrics in the Moneyview IPO discussion. Across the recorded period, GMP ranged from Rs 3 to Rs 15, based on social tracker summaries. On September 29, posts cited GMP around Rs 12.75, implying an indicative listing price of about Rs 46.75 against the Rs 34 upper band, or roughly a 37.5 percent premium. By September 30, some trackers showed GMP in the Rs 13 to Rs 14 range, while another widely shared snapshot put “live GMP” at Rs 14.5 and an estimated listing price at Rs 48.5. One update noted GMP fell by Rs 1 from the previous recorded quote, which was described as a mild correction after stronger initial-phase quotes around Rs 15 to Rs 15.50. Multiple posts also carried a standard caution - GMP is unofficial and does not guarantee actual listing price or post-listing performance. The key value of GMP in these threads was as a sentiment proxy rather than a promise.

Allotment date, refunds, and demat credit timeline

The basis of allotment was widely reported as scheduled for September 29, 2026. This timing became a key search trend because applicants typically check status multiple times on allotment day. Posts also highlighted the expected next steps: refunds for non-allottees and credit of shares to successful applicants on September 30. For first-time applicants, several explainers clarified that status can be checked on the registrar website as well as on NSE and BSE portals. The same posts repeated that listing is scheduled for October 1 on both exchanges. This tight timeline has kept the IPO in social conversation even after the bidding closed. Many threads shared simple guidance to keep application details handy for status checks. Others reminded users that demat credit may show up at different times depending on intermediaries, even when the expected date is the same. The unifying point across posts was that September 29 to October 1 is the critical window for updates.

Allotment probability chatter: what was shared and what it means

Apart from official timelines, a separate stream of posts focused on allotment probability estimates circulating online. One widely shared note presented category-level probabilities and share counts in a simplified format. It stated that in the big HNI category (bNII), 1 investor out of 28 investors may get 6,174 shares, shown with a probability of 3.57 percent. For the small HNI category (sNII), it stated 1 out of 84 investors may get 6,174 shares, shown with a probability of 1.15 percent. For the retail category, it stated 1 out of 17 investors may get 441 shares, shown with a probability of 5.88 percent. These figures were shared as informal estimates rather than official allocation rules. Social responses used them mainly to set expectations in an oversubscribed issue. The important practical point repeated in comments was that a high subscription often means many applicants receive no allotment at all. As a result, retail focus stayed on checking status rather than assuming allotment.

Listing-day expectations for October 1: what people are watching

With listing scheduled for October 1, the core discussion is how GMP-based estimates compare with the first traded price. Several posts used GMP of around Rs 12.75 to project a listing near Rs 46.75, while others used Rs 14 to Rs 14.5 to suggest Rs 48 to Rs 48.5. The same threads also highlighted that GMP can change quickly, including in the final hours before listing. This is why many users track the latest quote rather than a single day’s number. A repeated caution in the discussion is that GMP is an unofficial indicator from the unlisted market and not a guarantee. Some users also pointed out the difference between implied listing price and actual realised gains, which depend on execution and liquidity at the open. Another angle that stayed consistent was that the IPO drew strong attention because it is a new-age fintech listing, even though the posts focused mainly on mechanics rather than business analysis. For applicants, the immediate checklist remains simple - confirm allotment, confirm demat credit, and then watch the opening trade on listing day.

Key takeaways from the trending thread

The social-media narrative around Moneyview IPO has been driven by measurable checkpoints rather than speculation alone. The first anchor was the 98.46 times subscription, frequently paired with the bids-versus-offer figures. The second anchor was the allotment schedule on September 29, followed by expected refunds and demat credit on September 30. The third anchor was GMP, which was quoted in a band from Rs 3 to Rs 15 over the tracking period. As of late September updates, GMP around Rs 12.75 to Rs 14.5 implied an indicative listing price roughly between Rs 46.75 and Rs 48.5 versus the Rs 34 upper band. At the same time, multiple posts repeated the standard warning that GMP does not guarantee listing or post-listing performance. The lot size of 441 shares became the practical unit for retail calculations and allotment expectations. The highest-intent searches and posts now revolve around allotment status checks on BSE, NSE, and the registrar sites. The next major data point for the market will be the actual listing price on October 1 and how it compares with the implied range discussed online.